LONDON–(BUSINESS WIRE)–#HumanMachineInterface–According to the global smart glasses market research report released by Technavio, the market is expected to post a CAGR of around 43% until 2022.
Category: Business
Invest in “Precision Health” to Better Care for High-Need, High-Cost Patients, AJMC® Researchers Say
CRANBURY, N.J.–(BUSINESS WIRE)–Invest in “Precision Health” to Better Care for High-Need, High-Cost Patients, AJMC® Researchers Say
Children’s Hospital Los Angeles Team Identifies Developmental Stage for No. 1 Eye Tumor in Children
LOS ANGELES–(BUSINESS WIRE)–Investigators at Children’s Hospital Los Angeles have been able to pinpoint the exact stage of development of the human retina, when cells can grow out of control and form cancer-like masses. The finding could open the doo…
Second Sight Receives $1.6 Million Grant from National Institutes of Health to Support Orion Clinical Development
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision…
Contact Lenses – Asia Pacific Markets (2018-2024): Analysis by Product, Design, Application and Country – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Contact Lenses Market Analysis (2018-2024)” report has been added to ResearchAndMarkets.com’s offering. The Asia Pacific Contact Lenses Market is expected to witness market growth of 9.2% CAGR during the forec…
Samenvatting: Vivior tekent overeenkomst met Kochoptik om Vivior’s systeem te evalueren
ZURICH–(BUSINESS WIRE)–Vivior heeft een overeenkomst getekend met Kochoptik, een premium opticiën in Zwitserland. Klanten van Kochoptik zullen Vivior’s Visual Behaviour Monitor gebruiken om een aanbeveling te krijgen voor een geïndividualiseerde zorg…
Vivior conclut un accord avec Kochoptik aux fins de l’évaluation du système de Vivior
ZURICH–(BUSINESS WIRE)–Vivior a signé un accord avec Kochoptik, un opticien suisse de haute qualité. Les clients de Kochoptik porteront le moniteur de comportement visuel de Vivior, ce qui conduira à une recommandation de solution individualisée de s…
Sun Pharma and SPARC Announce US FDA Approval of XELPROS™ to Treat Open-angle Glaucoma or Ocular Hypertension
MUMBAI, India & PRINCETON, N.J.–(BUSINESS WIRE)–#BAK–Sun Pharma’s XELPROS™ (latanoprost ophthalmic emulsion) 0.005% approved by the U.S. FDA
STAAR Surgical Announces Approval by the FDA of the Visian Toric ICL for the Correction of Myopia with Astigmatism
MONROVIA, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today announcing that the FDA has granted approval of the PMA …
The Global $18bn Contact Lenses Market by 2024: Key Driver & Opportunity Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Contact Lenses Mask Market Analysis (2018-2024)” report has been added to ResearchAndMarkets.com’s offering. The Global Contact Lenses Market size is expected to reach $18 billion by 2024, rising at a market growth …
Vivior Signs Agreement with Kochoptik to Evaluate Vivior’s System
ZURICH–(BUSINESS WIRE)–Vivior has signed an agreement with Kochoptik, a premium optical retailer in Switzerland. Kochoptik’s customers will wear Vivior’s Visual Behavior Monitor to provide a recommendation for an individualized vision care solution. …
The Global Eyewear Market with Focus on Premium Eyewear (2018-2022) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Eyewear Market with Focus on The Premium Eyewear (2018-2022 Edition)” report has been added to ResearchAndMarkets.com’s offering. The global eyewear market has increased with a healthy growth rate over the years and…
More than 180 Children’s Hospital Los Angeles Physicians Named “Top Doctors” in Annual List Honoring the Region’s Most Esteemed Specialists
LOS ANGELES–(BUSINESS WIRE)–More than 180 Children’s Hospital Los Angeles physicians were named Top Doctors by Pasadena Magazine, honoring the region’s most esteemed specialists.
In Australia, NovaTears® Eye Drops Are Available on the Pharmaceutical Benefits Scheme (PBS) from Now On
HEIDELBERG, Germany–(BUSINESS WIRE)–#AFT–Novaliq GmbH, a specialty pharmaceutical company with the first water-free technology platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, is the manufacturer of NovaTe…
The $65.25Bn Global Ophthalmic Devices Market to 2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Devices Market – Forecasts from 2018 to 2023” report has been added to ResearchAndMarkets.com’s offering. The ophthalmic device market is projected to grow at a CAGR of 5.01% to reach US$65.248 billion in 2023 f…
Uveitis – Epidemiology Forecast to 2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Uveitis – Epidemiology Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering. Uveitis – Epidemiology Forecast, 2025 provides an overview of the epidemiology trends of Uveitis in seven major markets (…
Global Eyewear Market by Product Type, Lens Material, End User, Distribution Channel and Geography – Forecast to 2023 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Eyewear Market – Segmented by Product Type, Lens Material, End User, Distribution Channel and Geography – Growth, Trends and Forecasts (2018 – 2023)” report has been added to ResearchAndMarkets.com’s offering. The g…
Mati Therapeutics Interim Phase II Nepafenac Clinical Trial Results Signal Significant Post-op Pain Reduction in Cataract Surgery Patients
AUSTIN, Texas–(BUSINESS WIRE)–Mati Therapeutics Inc. (“Mati”) announced that it has completed a planned interim analysis of an ongoing Phase II clinical trial evaluating the safety and efficacy of nepafenac delivered in Mati’s proprietary Evolute® sustained ocular drug delivery platform. The trial is a multi-center, randomized, masked evaluation of nepafenac vs. placebo in 75 patients undergoing cataract surgery. The primary endpoint is to evaluate pain and the secondary endpoint is to evalua
Second Sight Appoints Pat Ryan Chief Operating Officer
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, announced today that Pat Ryan has been appointed Chief Operating Officer, effective immediately. In this newly created role, Mr. Ryan will assume responsibility for Research & Development, Manufacturing, Planning & Ma
2020 On-site appoints Alexis McLaughlin as Chief Executive Officer, Closes Over $5MM in Series B Financing and Named to the Inc. 5000
BOSTON–(BUSINESS WIRE)–#HR–2020 On-site (2020), America’s leading provider of on-site vision care for businesses and schools, serving over 450 leading employers, announced this morning the appointment of Alexis McLaughlin as 2020’s new Chief Executive Officer. McLaughlin will also join 2020’s Board of Directors. Most recently, McLaughlin was SVP/General Manager of Retail Licensed Brands at Luxottica Retail, where she was responsible for $500MM in revenue across 1,000 stores in North America. In h